The Celebrity-Backed Bitcoin Gamble That Didn’t Pay Off

In June 2025, Prenetics Global Limited launched a bold initiative that drew attention from both the crypto and health tech sectors. The Nasdaq-listed company, with the backing of football legend David Beckham, adopted a Bitcoin accumulation strategy inspired by Michael Saylor’s approach. The plan was straightforward: raise capital to buy Bitcoin continuously—one BTC per day—with a five-year goal of reaching $1 billion in both revenue and Bitcoin holdings. This move was a major bet on the long-term viability of cryptocurrency as a corporate reserve asset, reflecting the optimism that once swept through health tech. However, just six months later, on December 4, the company abruptly reversed course. Prenetics announced a full stop to its Bitcoin purchasing program, shifting all resources to the development of its nutritional supplement brand, IM8. The decision shocked investors and raised doubts about the company’s true commitment to crypto strategies. Although Prenetics still held 510 Bitcoin—worth about $45 million at the time—the company concluded that further accumulation no longer fit its operational direction. This sudden pivot made one thing clear: regardless of celebrity endorsements or bold strategies, every corporate crypto initiative must ultimately withstand real-world market pressures and operational demands.

When Health Tech Met Crypto: Prenetics’ Bold Experiment and Sudden Exit

The convergence of health tech and crypto initially made for a compelling story among market watchers. Earlier in the year, Prenetics raised $48 million, allocating part of it to build a Bitcoin reserve. The company framed its digital asset strategy as complementary to—not in conflict with—its core business. Leadership announced that Bitcoin accumulation would proceed alongside the explosive growth of IM8, which surpassed $100 million in annual recurring revenue within just 11 months, before the strategic reversal. This dual-track approach showed confidence in both the nutritional supplement and crypto sectors. But reality proved different. After only half a year, Prenetics’ leadership realized that many companies abandon Bitcoin investment plans due mainly to resource constraints and the need for strategic focus—issues that only become apparent in execution. The company’s decision wasn’t a rejection of Bitcoin, but an acknowledgment that capital allocation requires clear priorities. IM8’s rapid growth compelled Prenetics to dedicate all resources and capital to that brand. The board’s decision on December 4 to stop buying Bitcoin demonstrated mature governance: understanding that, no matter how important reserve strategies seem, they cannot outweigh core business momentum. This case shows that—even with celebrity backing—corporate crypto decisions require a careful balance between diversification ambitions and operational efficiency in the main business.

The Broader Pattern: Why Corporate Bitcoin Treasury Strategies Are Collapsing in 2025

Prenetics isn’t alone in reversing its Bitcoin treasury strategy. The company is one of many that aggressively accumulated crypto during bullish markets, only to pull back as conditions shifted or operational realities forced a reassessment. This trend marks a shift in how businesses view digital assets as treasury reserves. Numerous companies that revamped their crypto policies through 2024 and into 2025 are now facing similar pressures. These firms confront several challenges that make further Bitcoin accumulation difficult to justify. Market volatility regularly disrupts balance sheets, clashing with traditional governance standards. Institutional investor skepticism around digital assets increases the pressure. Justifying digital asset strategies to cautious stakeholders requires robust arguments, not just belief in Bitcoin’s long-term potential.

Prenetics’ shift away from Bitcoin shows how quickly corporate enthusiasm can fade when market realities intervene. The company started 2025 with a serious commitment to daily Bitcoin purchases, but by year’s end, changing market conditions and outperformance in its core business forced a change in financial strategy. Prenetics’ board determined that focusing capital on IM8’s expansion would yield more measurable results than continued Bitcoin accumulation in a weak market. This is a fundamental re-evaluation of risk and return—a process now underway at many boards reviewing digital asset exposure.

Learning from Prenetics: What Companies Should Know About Crypto Strategy Reversals

Prenetics’ experience offers essential lessons for business leaders considering or already executing crypto treasury strategies. First, committing to enterprise-level Bitcoin accumulation requires real conviction—beyond market cycles. Prenetics’ six-month trial revealed that, when competition for resources intensifies, practical operational needs outweigh belief. Companies should define clear points to revisit strategy rather than promise indefinite accumulation regardless of market context. Second, celebrity backing doesn’t help a strategy withstand strict financial scrutiny. Beckham added initial appeal and credibility, but couldn’t influence the board’s decision on capital efficiency for IM8. Investors and stakeholders are increasingly drawing clear lines between symbolic value and genuine financial substance, especially regarding corporate treasury policies.

Third, companies evaluating why they’ve abandoned Bitcoin investment must realize these decisions often reflect operational maturity, not a change in principle. Prenetics kept its 510 Bitcoin as reserves, not liquidating them, signaling sustained belief in digital assets but prioritizing strong capital discipline. This approach acknowledges Bitcoin’s potential while keeping resource control at the forefront. Fourth, health tech companies weighing Bitcoin adoption must consider industry-specific constraints. Health tech faces stricter legal and compliance requirements than other tech or financial sectors, which limits the ability to take on alternative asset risk without jeopardizing core business focus.

For organizations evaluating crypto strategies, Prenetics’ case shows that market conditions at launch rarely match those just six months later. Companies that set Bitcoin accumulation goals based on certain market assumptions have learned: as volatility shifts, so must the financial logic. Experience also shows that core business performance always takes priority for capital allocation—especially when the core business is growing as quickly as IM8 with $100 million ARR. Companies can maintain crypto exposure but need the flexibility to adjust strategy as necessary. The key is proactively reassessing, not just reacting. Prenetics took this proactive approach: halting new purchases but holding existing Bitcoin—a balanced model for others. Those interested in corporate finance strategy during this period can learn more from platforms like Gate, which deliver comprehensive crypto market analysis and support tools for investors and senior strategists assessing digital asset exposure.